Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1721-1726
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1721
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1721
Author | Year | No. patients | Study design | No. of pathologists, blinding | Stain | Tumoursite | Elastin stain | No. EMVI +ve pts | Prev VI +ve | EMVI +ve 5 yr survival | Independent prognosticator |
Brown et al[29] | 1938 | 170 | Retrospective | Unspecified | H + E | Rectum | Yes | 104 | 61% | No 5 yr data | No comment |
Dukes et al[30] | 1941 | 689 | Prospective | Unspecified | No stain | Rectum | No | 107 | 17% | No 5 yr data | No comment |
Seefeld et al[13] | 1943 | 100 | Prospective | 1, blinded | H + E, Gieson’s | Rectum | Yes | 20 | 20% | 5% | No comment |
Madison et al[31] | 1954 | 42 | Prospective | Unspecified | Brominol, H + E, Gieson’s | Rectum | Yes | 19 | 43% | No 5 yr data | No comment |
Carroll[17] | 1963 | 1996 | Retrospective | Unspecified | H + E | Rectum | No | 240 | 11.8% | 36% | No comment |
Khankhanian et al[32] | 1977 | 143 | Retrospective | Unspecified | Not stated | Rectum | No | 70 | 19% (BVI + LVI) | Data not usable | EMVI is +ve IPS |
Talbot et al[6] | 1980 | 706 | Prospective | 2, blinded | H + E, elastin | Rectum | Yes | 366 | 52% | 33% EMVI+ve | No comment |
Rich et al[15] | 1983 | 142 | Prospective | 1, blinded | H + E | RS/Rectum | No | 23 | 17% | No 5 yr data | No comment |
Freedman et al[4] | 1984 | 494 | Retrospective | Unspecified | No comment | Rectum | Yes | 89 | 36% | 31% EMVI+ve | No comment |
Jass et al[16] | 1986 | 447 | Prospective | 1, blinded | H + E | Rectum | No | 116 | 26% (extramural only) | 41% EMVI+ve | EMVI - No IPS |
Sasaki et al[33] | 1987 | 774 | Retrospective | Unspecified | H + E | Rectum | No | 163 | 21% (extramural only) | No 5 yr data | No comment |
Minsky et al[14] | 1988 | 168 | Retrospective | 1, blinded | H + E, elastin | RS/Rectum | Yes | 81 | 48% | 33% EMVI+ve | EMVI - No IPS |
Harrison et al[2] | 1994 | 348 | Retrospective | 2, blinded | H + E, elastin | Rectum | Yes | 74 | 21.2% | 21% EMVI+ve | EMVI has IPS |
Ptok et al[18] | 2006 | 1043 | Retrospective | Unspecified | Not state | Rectum | No | 75 | 9% | 80.7% LVI +ve | EMVI - No IPS |
- Citation: Chand M, Siddiqui MR, Swift I, Brown G. Systematic review of prognostic importance of extramural venous invasion in rectal cancer. World J Gastroenterol 2016; 22(4): 1721-1726
- URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1721.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1721